FINWIRES · TerminalLIVE
FINWIRES

SHE:002022

4 stories mentioning SHE:002022Updated 48d ago

Every FINWIRES story that references SHE:002022, newest first.

Asia

Kehua Bio-Engineering's Unit Gets Registration Certificate for Metapneumovirus Nucleic Acid Kit

Shanghai Kehua Bio-Engineering's (SHE:002022) unit, Suzhou Tianlong Biotechnology, received a medical device registration certificate from China's National Medical Products Administration for a swab kit for metapneumovirus nucleic acid, according to a Shenzhen bourse filing on Thursday.The certificate for the human metapneumovirus nucleic acid detection kit is valid until May 10, 2031.The Chinese in vitro diagnostics company's shares fell 2% during the afternoon trade.

SHE:002022
Asia

Kehua Bio-Engineering Gets Registration Certificate for Nucleic Acid Kit

Shanghai Kehua Bio-Engineering (SHE:002022) received a medical device registration certificate from China's National Medical Products Administration, according to a Shenzhen bourse filing on Wednesday.The certificate, which is valid until May 10, 2031, is for the fully automated nucleic acid purification and amplification detection system.The Chinese in vitro diagnostics company's shares slipped 1% at the close.

SHE:002022
Asia

Shanghai Kehua Bio-Engineering Obtains Registration for HDL3-C Test Kit

Shanghai Kehua Bio-Engineering (SHE:002022) obtained medical device registration from the Shanghai regulator for its high-density lipoprotein 3 cholesterol assay kit.The kit is intended for in vitro quantitative determination of HDL3-C concentration in human serum and plasma samples, according to a Tuesday filing with the Shenzhen bourse.The registration is valid until May 6, 2031.Shares of the in vitro diagnostics company closed 3% lower Tuesday.

SHE:002022
Asia

Kehua Bio-Engineering Obtains Shanxi Regulator's Approval for Chemiluminescence Analyzer

Shanghai Kehua Bio-Engineering (SHE:002022) unit Kehua Xi'an Bio-engineering obtained medical device registration from the Shaanxi regulator for its fully automated chemiluminescence immunoassay analyzer.The device is used in detecting hormones and autoantibodies in human serum and plasma, according to a Thursday filing with the Shenzhen bourse.The certificate is valid until April 29, 2031.

SHE:002022

Track with the FINWIRES app suite

FolioX
FolioX
Track SHE:002022 in your portfolio
WheelAI
WheelAI
Analyze SHE:002022 options with the wheel strategy
StockInsider
StockInsider
See market sentiment on SHE:002022